Clinical Trial Update: Propranolol Adjuvant Treatment of Focal Refractory Epilepsy (PATFRE) [EARLY_Phase 1]

View source ↗

Summary

This clinical trial update outlines a Phase 1 study of propranolol as an adjuvant treatment for focal refractory epilepsy, which is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Drug-resistant Epilepsy
• Epilepsy

Drugs mentioned

• Propranolol (propranolol)

Snippet

Sponsor: Xuanwu Hospital, Beijing | Conditions: Epilepsy, Drug Resistant | EARLY_Phase 1 | Status: NOT_YET_RECRUITING